Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-ketoglutarate for Age-related Ocular Disease
NCT07269704Phase 1Completed
- Sponsor
- Stanford University
- Start
- Aug 2023
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Age-related eye disease (ARED), sponsored by Stanford University. Primary endpoint: Mean change in aqueous humor alpha-ketoglutarate level at 28 days. Started Aug 2023; status: completed.
02
Conditions
Age-related eye disease (ARED)
Beyond the preview
Go deeper on NCT07269704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07269704.